Meftal Tablets

MEFTAL-SPAS® Tablet

MEFTAL-SPAS® is a balanced antispasmodic and analgesic formulation indicated for the symptomatic relief of smooth muscle spasms and associated visceral pain.

Clinical Applications

Most popular clinical applications:
Dysmenorrhea

Dysmenorrhea

Learn More
Intestinal Colic

Intestinal Colic

Learn More
Renal Colic

Renal Colic

Learn More
Biliary Colic

Biliary Colic

Learn More

More Clinical Application

Gynaecology Primary and secondary dysmenorrhea; relief of uterine contractions and pelvic pain.
Gastroenterology Intestinal colic, irritable bowel syndrome (IBS), and spasmodic pain associated with enteritis or colitis.
Urology Renal colic and ureteric spasms caused by calculi or infection.
Hepatobiliary Biliary colic and spasms of the gallbladder or bile ducts.

Prescribing Guidelines by Age

MEFTAL-SPAS® product range is formulated to provide age-appropriate dosing across the patient lifecycle. While the tablet is the primary form for adults and adolescents, the brand provides specialised delivery systems for younger demographics.

Patient Age Group Recommended Format Typical Clinical Use
Infants (up to 6 months) Drops Infantile colic and gastric distress.
Children (6 months - 12 years) Suspension Pediatric abdominal pain and bloating.
Adolescents (12+ years) Tablet Monthly period pain and functional GI spasms.
Adults Tablet Biliary, Renal, and Intestinal colic.
Adults (Acute Care) Injection Severe, sudden spasms requiring rapid onset.

Pharmacological Highlights for the Physician

  • Dual Mechanism :
    Combines the anticholinergic effect of Dicyclomine HCl (to stop the spasm) with the anti-prostaglandin effect of Mefenamic Acid (to stop the pain).
  • Rapid Absorption :
    Optimized for quick onset, typically providing relief within 30 to 60 minutes.
  • Proven Safety :
    Established clinical profile with over three decades of trusted use in the Indian healthcare ecosystem.

Prescribing Information

Generic Name

Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP

(Brand Name: MEFTAL-SPAS ® Tablets / MEFTAL-SPAS ®; DS Tablets)

Qualitative and Quantitative Composition

MEFTAL-SPAS® Tablets

Each uncoated tablet contains:

Mefenamic Acid IP - 250 mg

Dicyclomine Hydrochloride IP - 10 mg

Colour: Tartrazine.

MEFTAL-SPAS® DS Tablets

Each uncoated tablet contains:

Mefenamic Acid IP - 500 mg

Dicyclomine Hydrochloride IP - 20 mg

Colour: Tartrazine.

Dosage Form and Strength

Dosage Form: Tablets.

Dosage Strength: Mefenamic acid 250 mg / 500 mg + dicyclomine hydrochloride 10 mg / 20 mg per tablet respectively.

Posology and Method of Administration

For oral administration in adults and adolescents.

  • MEFTAL-SPAS® Tablets

    1 to 2 tablets to be administered three times daily.

  • MEFTAL-SPAS® DS Tablets

    1 tablet to be administered three times daily.

Treatment is generally required till the time dysmenorrhea symptoms persist i.e., 3 to 5 days during the menses. MEFTAL-SPAS® / MEFTAL-SPAS® DS Tablets should be taken preferably with or after food. Or, as prescribed by the physician.

Contraindications

MEFTAL-SPAS® / MEFTAL-SPAS® DS Tablets are contraindicated in the following

  • Known hypersensitivity to mefenamic acid or to dicyclomine or to any component of the formulation.
  • Pre-existing asthma and aspirin-sensitive asthma.
  • Active ulceration/bleeding or chronic inflammation of upper or lower gastrointestinal (GI) tract.
  • Treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
  • Pre-existing renal disease/obstructive uropathy.
  • Glaucoma.
  • Myasthenia gravis.
  • Last trimester of pregnancy.
  • Lactation.
  • Inflammatory bowel disease, paralytic ileus and intestinal atony.

Possible Side Effects (Safety Information)

For detailed quantitative, and qualitative composition, therapeutic indications, posology and method of administration, contraindications, special warnings and precautions for use, drug interactions, undesirable effects, overdose, mechanism of action, pharmacodynamic properties of MEFTAL-SPAS® Tablets, MEFTAL-SPAS® DS Tablets, download the note.